September 22, 2015 / 5:39 AM / 2 years ago

BRIEF-Nicox and Bausch & Lomb announce FDA acceptance of new drug application for Vesneo

Sept 22 (Reuters) - Nicox SA :

* Bausch & Lomb and Nicox announce FDA acceptance of new drug application for novel glaucoma candidate Vesneo (latanoprostene bunod)

* FDA has set an action date of July 21, 2016 to complete its review, as per the Prescription Drug User Fee Act (PDUFA)

Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below